Infantile-Onset Pompe Disease Requiring Intensive Immunomodulation Therapy
SIMD EDUCATION COMMITTEE WEBINAR SERIES
This session will be a trainee presentation of infantile-onset Pompe disease cases followed by commentary by experts.
Commercial Supporter
This educational activity is supported by an educational grant from Ultragenyx.
Learning Objectives
- Recognize the presentation of infantile-onset Pompe disease.
- Adapt the immunomodulation therapy to meet the patient needs.
- Summarize the ethical aspects of newborn screening for Krabbe disease.
Medical Biochemical Genetics is hosted virtually via Zoom. Zoom details will be provided after registering for the course.
Moderators
Jaya Ganesh, MD
Mount Sinai
Mari Mori, MD
Ohio State University
Expert Commentators
Jaap-Jan Boelens, MD, PhD
Memorial Sloan Kettering
Priya S. Kishnani, MD, MBBS
Duke University
Dietrich Matern, MD, PhD
Mayo Clinic
Disclosures
Jaap-Jan Boelens, MD, PhD, speaker for this activity, is a speaker for Sanofi and Sobi.
Priya Kishnani, MD, speaker for this activity, is a consultant for Sanofi Genzyme, Takeda Pharmaceuticals, AlnylamPharmaceuticals and Amicus Therapeutics, is on an advisory board for Sanofi Genzyme, AlnylamPharmaceuticals and Amicus Therapeutics, and is a researcher for Sanofi Genzyme, Takeda Pharmaceuticals and Amicus Therapeutics.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance

Facebook
X
LinkedIn
Forward